877-202-0205     support@chemchart.com     @chemchart
        
Sign In    Register
   Reset Filters

Polycyclic organic compounds, Six-membered rings, Heterocyclic compounds

Categories

Cyclic compounds (6)
Heterocyclic compounds (4 or more rings) (5)
Organic peroxides (5)
Trioxanes (5)
Antineoplastic and immunomodulating drugs (3)
Antineoplastic drugs (3)
Experimental cancer drugs (3)
Pharmaceuticals (2)
Antidepressants (1)
Antipsychotics (1)
Atypical antipsychotics (1)
Dopamine antagonists (1)
Drugs acting on the nervous system (1)
Heterocyclic compounds (bridged-ring) (1)
Mood stabilizers (1)
Piperazines (1)
Psychoactive drugs (1)
Psychoanaleptics (1)
Psychopharmacology (1)

Suppliers

AK Scientific (2)
Oakwood Chemical (1)
TCI Chemicals (1)

Lurasidone (367514-88-3, 367514-87-2)  
Lurasidone (trade name Latuda) is an atypical antipsychotic developed by Dainippon Sumitomo Pharma and marketed by Sunovion in the U.S. It has been an FDA approved treatment for schizophrenia since 2010 and for treating depressive episodes in adults with bipolar I disorder since 2013. It can be used alone or in combination with mood stabilizers such as lithium or valproate (e.g., Depakote).
Dihydroartemisinin (81496-81-3, 71939-50-9)  
Dihydroartemisinin (also known as dihydroqinghaosu, artenimol or DHA) is a drug used to treat malaria. Dihydroartemisinin is the active metabolite of all artemisinin compounds (artemisinin, artesunate, artemether, etc.) and is also available as a drug in itself. It is a semi-synthetic derivative of artemisinin and is widely used as an intermediate in the preparation of other artemisinin-derived antimalarial drugs.
artemisinin (63968-64-9)  
qinghaosu  ·  quinghaosu  ·  artemisinine
Artemisinin, also known as qinghao su (Chinese: 青蒿素), and its semi-synthetic derivatives are a group of drugs used against Plasmodium falciparum malaria. It was discovered by Tu Youyou, a Chinese scientist, who was awarded half of the 2015 Nobel Prize in Medicine for her discovery. Treatments containing an artemisinin derivative (artemisinin-combination therapies, ACTs) are now standard treatment worldwide for P.
AC1LD383 (63968-64-9)  
Artemisinin, also known as qinghao su (Chinese: 青蒿素), and its semi-synthetic derivatives are a group of drugs used against Plasmodium falciparum malaria. It was discovered by Tu Youyou, a Chinese scientist, who was awarded half of the 2015 Nobel Prize in Medicine for her discovery. Treatments containing an artemisinin derivative (artemisinin-combination therapies, ACTs) are now standard treatment worldwide for P.
Artenimol (71939-50-9)  
Dihydroartemisinin (also known as dihydroqinghaosu, artenimol or DHA) is a drug used to treat malaria. Dihydroartemisinin is the active metabolite of all artemisinin compounds (artemisinin, artesunate, artemether, etc.) and is also available as a drug in itself. It is a semi-synthetic derivative of artemisinin and is widely used as an intermediate in the preparation of other artemisinin-derived antimalarial drugs.
Related searches
Polycyclic organic compounds
Six-membered rings
Heterocyclic compounds